Skip to main content
InPharmacy - return to the homepage InPharmacy logo
  • Search
  • Visit InPharmacy on Linked In
  • Visit InPharmacy on Twitter
  • Visit InPharmacy on Facebook
  • Visit InPharmacy on YouTube
Visit the
National Pharmacy Association National Pharmacy Association

Main navigation

  • NPA News
  • Your Pharmacy
  • Member Benefits
  • Topics
Quick links:
  • Home
  • Categories
  • Your Pharmacy
  • Advice & Support
Patient Safety
NPA News

Medication Safety Officer report Q3 2019

Share on
  • Whatsapp
  • Twitter
  • Facebook
  • Linked in
  • Mail
  • Print
Open-access content Sunday 13th January 2019 — updated 11.02am, Thursday 20th January 2022

The NPA holds the Medication Safety Officer (MSO) role for all community pharmacies in England with fewer than 50 branches. Here are some of the findings from the July to September (quarter three) report.

Medication safety officer report

The NPA holds the Medication Safety Officer (MSO) role for all community pharmacies in England with fewer than 50 branches. Here are some of the findings from the July to September (quarter three) report.

There was a 25% increase in the total number of patient safety incidents reported in quarter three of 2019, compared to quarter two.

Origin of Patient Safety Incidents

A total of 92% of incidents originated from the pharmacy. There were 5% of errors reported that were prescribing errors – this is a 3% increase from quarter two. It is important to report prescribing errors because increased reporting allows identification of trends and increases learning. The most common type of error reported during quarter three was “dispensing error”, which accounted for 86% of all reported incidents.

Insulin 1 Insulin 2
Humulin I Humalog
Humulin I Humulin M
Humulin I Novmix 30
Lantus Humalog
Novomix Novorapid

Medication error categories

The main categories of error reported were those involving medication errors such as wrong strength, drug or formulation. These accounted for 62.7% of errors. 

  • “Wrong strength” accounted for 26.2% of errors
  • “Wrong drug/medicine” accounted for 25% 
  • “Wrong formulation” 11.5%

Errors involving insulin were reported in both the “wrong drug/medicine” and “wrong formulation” categories. “Wrong formulation” incidents were mainly due to pre-filled pens and cartridges being mixed up. There have been multiple “wrong drug/medicine” incidents reported with different brands of insulin. Insulins should be prescribed by brand name as different brands often have different instructions for use and therefore patient training is required.

The table, below, shows which insulins were dispensed in place of each other over quarter three.

Degree of Harm Caused to Patients

The degree of harm caused to patients reported as “none” (56%) and “near miss’ (30%) continued to make up the majority of reports.

The data reported over quarter three highlighted both good and poor reporting. All the reports submitted where the degree of harm was reported as “death” or “severe” were incomplete. This meant that no analysis could be undertaken on the root cause of these incidents or follow up with the pharmacies. Due to the poor reporting, it is not known if these incidents actually caused death or severe harm or if reports were completed incorrectly. When documenting the degree of harm caused to patients, the actual degree of harm should be documented, not the potential harm that could have arisen.

facts and figures

Self-checking

Self-checking is defined as a pharmacist carrying out all steps in the dispensing process themselves, including the clinical check of the prescription and accuracy check of the assembled items. There was a 1% decrease in the number of errors reported which involved a pharmacist self-checking compared with quarter two.

Refer to the NPA “dispensing process – best practice guide” that includes guidance for self-checking prescriptions. It is on the NPA website.

Top LASA errors as identified by NHS Improvement   Percentage from total LASA errors
Amlodipine Amitryptiline 3
Atenolol Allopurinol 2
Azithromycin Azathioprine 0
Carbamazepine Carbimazole 0
Propranolol Prednisolone 0
Rosuvastatin Rivaroxaban 1

Factors Contributing  to incidents

“Work and environment factors” (39.6%) continues to be the main contributing factor reported. This category includes time pressures, understaffing and poorly organised working environments. 

“LASA” (look-alike, sound-alike) at 23.6% was the second largest contributing factor to errors reported. 

The percentage of each of the top “LASA” errors (as identified by NHS Improvement) reported in quarter three are listed in the table below. In addition to the “LASA” errors highlighted as high risk by NHS Improvement, 2.5% of all reported “LASA” errors involved Gabapentin and Pregabalin. 

The reclassification of these medicines as schedule 3 controlled drugs may have raised awareness of reporting and may be contributing to the large number of incidents reported where these two medicines have been mixed up. There have been reports of severe harm.

figures 3

 

Image credit: iStock
Topics:
Advice & Support
Patient Safety
NPA News

You might also like...

Today's top reads

Sign up to stay up to date

Subscribe

Why not become a member?

Find out more

Looking for a resource?

Read More
​
FOLLOW US
@NPA1921
National Pharmacy Association
National Pharmacy Association
CONTACT US
InPharmacy
Tel: (+44) 01727 858687
​

NPA

About NPA
Become a member
Services & Support
Events

Information

Privacy Policy
Terms & Conditions
Cookie Policy
Sign in or create an account

Get in touch

Contact us
Advertise with us
Write for InPharmacy

General

Pharmacy Careers
Business Partner
Insurance
Representing You

NPA InPharmacy Logotype

© 2022 • InPharmacy is produced by Redactive Media Group. All rights reserved. Reproduction of any part is not allowed without written permission.

Redactive Media Group Ltd, 71-75 Shelton Street, London WC2H 9JQ

 

 

  • Sign in
  • Create account
  • Business Support & Development
  • Learning & Development
  • Advice & Support
  • Insurance
  • Membership
  • Representing You
  • ADVICE AND SUPPORT
    • Key Notes
    • Patient Safety
    • Regulations and Legislation
    • Diary Dates
    • Pharmacy Services
  • BUSINESS SUPPORT & DEVELOPMENT
    • Technology & Data
    • Employment Law & HR
    • Health & Safety
    • Business Operations
    • Recommended Partners
  • LEARNING & DEVELOPMENT
    • Professional Development
    • You and Your Pharmacy Team
    • New Training Initiatives
  • INSURANCE
    • Business Insurance
    • Personal Insurance
    • Professional Indemnity
  • REPRESENTING YOU
    • Campaigns and lobbying
    • Opinions & Ideas